Home > Income Statement > WANBURY

WANBURY
Revenue

    Back to Income Statement
WANBURY is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for WANBURY
Please provide your vote to see the results

WANBURY Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹600 Cr₹578 Cr₹500 Cr₹511 Cr₹393 Cr

What is the latest Revenue of WANBURY ?

The latest Revenue ratio of WANBURY is ₹600 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹600 Cr
Mar2024₹578 Cr
Mar2023₹500 Cr
Mar2022₹511 Cr
Mar2021₹393 Cr

How is Revenue of WANBURY Trending?

Years Revenue % Change
Mar2025 ₹600 Cr
3.77
Mar2024 ₹578 Cr
15.63
Mar2023 ₹500 Cr
-2.26
Mar2022 ₹511 Cr
30.23
Mar2021 ₹393 Cr -

Compare Revenue of peers of WANBURY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WANBURY ₹1,173.0 Cr 25.1% 22.4% 11% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,507.0 Cr 2.8% 7.4% 14.5% Stock Analytics
DIVIS LABORATORIES ₹190,744.0 Cr 6.4% 8.3% 0.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹168,250.0 Cr 2.1% 8.7% 47.7% Stock Analytics
CIPLA ₹116,213.0 Cr 0.5% 3.6% -5.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,980.0 Cr -7.6% -2.2% -5.8% Stock Analytics


WANBURY Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WANBURY

25.1%

22.4%

11%

SENSEX

-1.4%

4.4%

-7.6%


You may also like the below Video Courses